Bonalive Biomaterials Ltd. granted FDA Breakthrough Device Designation for a bone graft substitute that potentially protects against microbial colonization
Bonalive Orthopedics granules (K191274) is distributed in the US by TriMed Bonalive Inc., a joint venture company between…